CASK and neoplasm: If the MCM/CMG reserves are already debilitated due to Myc’s actions, then administering a CMGi has the propensity to make a bad situation worse, further inactivating the remaining (now limited) reserve CMG helicases and likely increasing the sensitization of tumor cells to fork stalling chemotherapy (Figure 2).